We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
BioShin Limited today announced the appointment of Dr. Zhihong (Sarah) Lu as Chief Medical Officer and Dr. Ma (Mary) Li as Chief Commercial Officer. Sarah will play a critical role in BioShin's clinical development of pipeline products in Asia-Pacific ...
Biohaven has advanced the formation of a wholly owned subsidiary, BioShin, a Shanghai based limited liability company, to develop and commercialize its late-stage migraine....